Monogram Orthopaedics Inc(MGRM)

POST2.050.000.00%19:53 EST

2.05+0.04+1.99%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- Monogram Technologies Q3 EPS $(0.16) Down From $(0.03) YoY
  Benzinga · 11-15 05:44
  Monogram Technologies Q3 EPS $(0.16) Down From $(0.03) YoY
- Monogram Technologies Reports Third Quarter 2024 Financial Results
  ACCESSWIRE · 11-15 05:05
  Monogram Technologies Reports Third Quarter 2024 Financial Results
- Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
  ACCESSWIRE · 11-12
  Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
- MGRM: Monogram Announces it has Received an Additional Information Request (AIR) from the FDA Regarding its Recent 510(k) Submission.
  Zacks Small Cap Research · 10-31
  MGRM: Monogram Announces it has Received an Additional Information Request (AIR) from the FDA Regarding its Recent 510(k) Submission.
- Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
  ACCESSWIRE · 10-29
  Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
- Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
  ACCESSWIRE · 10-16
  Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
- CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
  ACCESSWIRE · 10-03
  CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
- Monogram Technologies' Application for mBos TKA System Placed on Hold by FDA
  MT Newswires Live · 10-03
  Monogram Technologies' Application for mBos TKA System Placed on Hold by FDA
- BRIEF-Monogram Technologies Receives Additional Information Request From FDA
  Reuters · 10-03
  BRIEF-Monogram Technologies Receives Additional Information Request From FDA
- Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
  ACCESSWIRE · 10-03
  Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
- Monogram Technologies Receives FDA Response for mBôs TKA System
  ACCESSWIRE · 10-03
  Monogram Technologies Receives FDA Response for mBôs TKA System
- Monogram Technologies: Got Additional Information Request From FDA on Sept 30, for Its 510(K) Premarket Filing Submission for MbÔS Tka System
  THOMSON REUTERS · 10-03
  Monogram Technologies: Got Additional Information Request From FDA on Sept 30, for Its 510(K) Premarket Filing Submission for MbÔS Tka System
- Monogram Technologies Announces Preferred Stock Dividends
  ACCESSWIRE · 10-01
  Monogram Technologies Announces Preferred Stock Dividends
- Monogram Technologies Upsizes Units Offering to $12.5 Million
  MT Newswires Live · 09-12
  Monogram Technologies Upsizes Units Offering to $12.5 Million
- Monogram Technologies Upsizes Units Offering to $12.5 Million
  MT Newswires Live · 09-12
  Monogram Technologies Upsizes Units Offering to $12.5 Million
- BRIEF-Monogram Technologies Upsized Continuous Offering Of Units To $12.5 Mln Units
  Reuters · 09-12
  BRIEF-Monogram Technologies Upsized Continuous Offering Of Units To $12.5 Mln Units
- Monogram Technologies: Upsized Continuous Offering of Units to $12.5 Mln Units
  THOMSON REUTERS · 09-12
  Monogram Technologies: Upsized Continuous Offering of Units to $12.5 Mln Units
- Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
  ACCESSWIRE · 09-12
  Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
- MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00
  Zacks Small Cap Research · 08-22
  MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00
- Monogram Technologies Inc. GAAP EPS of -$0.11 misses by $0.02
  seekingalpha · 08-15
  Monogram Technologies Inc. GAAP EPS of -$0.11 misses by $0.02
Company Profile
Company Name
Monogram Orthopaedics Inc
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.monogramorthopaedics.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.
- 11-14
  Quarterly Report
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 11-14
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 10-29
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 10-03
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 10-02
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 10-01
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 09-12
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 08-19
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 08-15
  Quarterly Report
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 08-12
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 08-08
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 07-22
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 07-12
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 06-12
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 05-15
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report

1D
5D
Day
Week
Month

High

2.08

Open

2.05

Volume%

1.52

Low

1.95

2.01

T/O Rate

0.54%

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

Monogram Orthopaedics Inc(MGRM)

Company Profile

Most Discussed